Impact of left bundle branch block in Takotsubo Syndrome

Jose Lopez1, Gustavo J Duarte2, Rosario A Colombo3

  • 1Department of Internal Medicine, HCA Florida Aventura Hospital, Aventura, FL, United States.

Insights

Left bundle branch block (LBBB) in takotsubo syndrome (TTS) patients is linked to increased ventricular arrhythmias but not sudden cardiac arrest or mortality. This suggests dyssynchrony may drive arrhythmias in TTS.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiomyopathy

Background:

  • Left bundle branch block (LBBB) exacerbates left ventricular dysfunction and dyssynchrony.
  • Takotsubo syndrome (TTS) is a form of cardiomyopathy often mimicking myocardial infarction.
  • The combined impact of LBBB and TTS on in-hospital outcomes requires further investigation.

Purpose of the Study:

  • To investigate the association between LBBB and in-hospital outcomes in patients diagnosed with TTS.
  • To determine if LBBB independently influences adverse events in TTS patients.

Main Methods:

  • Utilized the National Inpatient Sample (NIS) database from 2016-2019.
  • Identified TTS admissions using ICD-10 codes.
  • Employed multivariate regression analysis to assess LBBB's effect on outcomes.

Main Results:

  • Analyzed 26,615 TTS admissions; LBBB patients were older with more comorbidities.
  • LBBB presence was significantly associated with ventricular arrhythmias (OR=1.97, p=0.028).
  • No significant association was found between LBBB and sudden cardiac arrest, acute heart failure, cardiogenic shock, or in-hospital mortality.

Conclusions:

  • Intraventricular dyssynchrony, potentially exacerbated by LBBB, may contribute to ventricular arrhythmogenesis in TTS.
  • Elevated catecholamines are a likely mechanism for arrhythmia development in TTS.
  • LBBB appears to increase the risk of ventricular arrhythmias in TTS patients.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
27
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
36
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
418
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37